English
日本語
signup
login
Repository
Search
Annotators
Editors
Evaluators
NEWS
Documentation
>
top
>
projects
>
hydroxychloroquine
> docs
hydroxychloroquine
Documents
(914)
JSON
TSV
source DB
source ID
text
size
updated at
# proj.
# Ann.
updated_at
PubMed
33044019
Hydroxychloroquine in hospitalized COVID-19 patients: Real world experience assessing mortality. INTRODUCTION: Hydroxychloroquine (HCQ) for COVID-19 is presently being used off-label or within a clini
1.63 KB
2020-11-19
20
1
2021-01-18
PubMed
33031797
Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment. Repurposing of approved antiviral drugs against severe acute respiratory syndrome coron
1.73 KB
2021-01-18
1
0
2021-01-18
PubMed
33031652
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. BACKGROUND: Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basi
2.01 KB
2021-01-18
1
1
2021-01-18
PubMed
33048372
Hydroxychloroquine and Maintenance Immunosuppression Use in Kidney Transplant Recipients: Analysis of Linked U.S. Registry and Claims Data. Hydroxychloroquine (HCQ) is an antimalarial drug with immuno
1.65 KB
2020-11-19
20
10
2021-01-18
PubMed
32231348
Emerging prophylaxis strategies against COVID-19. The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020
481 Bytes
2020-04-08
32
0
2021-01-18
PubMed
33037151
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly
1.79 KB
2021-01-18
1
0
2021-01-18
PubMed
33041111
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence. INTRODUCTION: There is a pressing need for COVID-19 transmission control and effective treatments. We
1.42 KB
2020-11-19
20
0
2021-01-18
PubMed
33035581
Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19? The possibility is examined that immunomodulatory pharmacotherapy may be clinically useful in managing the pandem
1.93 KB
2020-11-19
21
1
2021-01-18
PubMed
33045775
The First Case of an HIV Patient Diagnosed with COVID-19 in Korea. Although some comorbidities, such as diabetes mellitus, lung disease, and chronic kidney disease, are known as risk factors for poor
1.17 KB
2021-01-18
1
8
2021-01-18
PubMed
33045596
A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections. Zinc and the combination with zinc ionophor
1.66 KB
2020-11-19
20
4
2021-01-18
Page 1